FDA panel votes against wider use of Amgen drug (Reuters)

[unable to retrieve full-text content]Reuters - An advisory panel on Wednesday recommended that U.S. health regulators reject the use of Amgen Inc's drug Xgeva to delay the spread of prostate cancer to the bone, dimming the chance of a wider use for one of the company's key growth drivers.

Source: http://us.rd.yahoo.com/dailynews/rss/diseases/*http%3A//news.yahoo.com/s/nm/20120208/hl_nm/us_fda_amgen_xgeva

girl with the dragon tattoo trailer parks and rec facebook announcement tyler clementi beebe michelle malkin goodrich